Case of atypical disseminated herpes zoster in a patient with COVID‐19: A diagnostic challenge in COVID era

Abstract

Herpes Zoster caused by reactivation of latent Varicella–Zoster virus (VZV). The rare disseminated form of it occurred mainly in immunocompromised patients. We hereby present the first case of atypical disseminated herpes zoster in a 54‐year‐old woman admitted with serious COVID. In this case, disseminated herpes zoster developed by purpuric lesions mimicking vasculitis and cutaneous drug reaction. Hence, this case serves as a reminder for considering atypical presentations of cutaneous disorders in immunocompromised patients, especially those affected with severe COVID.

Morphea in two patients after being infected to and being vaccinated against SARS‐CoV‐2 infection

“…Since the emergence of the SARS-CoV-2 pandemic, various dermatological manifestations have been demonstrated both following the de novo infection and the associated vaccination. [1][2][3][4] These cutaneous adverse events have been either a new-onset dermatologic disorder or exacerbation of the pre-existing one. 5,6 The new-onset or flare-up of psoriasis, lichen planus, eczematous dermatitis, and many other dermatoses have been reported following COVID-19.…”

“…Since the emergence of the SARS‐CoV‐2 pandemic, various dermatological manifestations have been demonstrated both following the de novo infection and the associated vaccination 1–4 5,6 …”

The role of SARS‐CoV‐2 infection and its vaccines in various types of hair loss

“…1 , 2 Apart from the respiratory and gastrointestinal manifestations, dermatologic involvement has been among the most prevalent presentations of SARS‐CoV‐2 infected patients. 3 , 4 , 5 , 6 This feature can be the first presenting symptom of the infection, may appear during the course of the disease, or even appear after the acute phase and recovery. Moreover, it may be a new‐onset cutaneous disorder or occur as an exacerbation of a pre‐existing dermatosis.…”

SARS‐CoV‐2 vaccination and practical points in psoriasis patients: A narrative review

“…Among them, local injection site reactions, urticarial eruptions and maculopapular rash have occurred with the highest frequency, most of which have been self-limited. [2][3][4][5][6][7] New-onset and exacerbation of some dermatological disorders, including lichen planus and psoriasis, have been reported following COVID-19 vaccination. 8 Psoriasis is a common chronic inflammatory dermatosis which can affect the skin, nails, and the axial and peripheral joints.…”